CSF EULAR Webinar Highlights Flyer
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Highlights</strong> from<br />
<strong>EULAR</strong> 2023<br />
<strong>CSF</strong> <strong>Webinar</strong><br />
Wednesday<br />
7 June 2023<br />
17.00–18.00<br />
BST<br />
Chair:<br />
Peter Nash<br />
Griffith University, Brisbane Australia<br />
Xavier Mariette<br />
Paris-Sud University Hospitals<br />
France<br />
New Safety and Efficacy<br />
of JAK Inhibitors in the<br />
Treatment of RA<br />
Lorenzo Dagna<br />
IRCCS San Raffaele Scientific<br />
Institute, Milan Italy<br />
Latest Cytokine Signalling<br />
and Treatment Targets<br />
in PsA<br />
Sofia Ramiro<br />
Leiden University Medical Center<br />
The Netherlands<br />
Emerging Therapies for<br />
the Treatment of axSpA<br />
With the continued release of new treatment data in RA,<br />
axSpa, and PsA, this webinar will highlight the key data<br />
presented at <strong>EULAR</strong> 2023. This session will review the<br />
latest safety and efficacy data of JAK inhibitors in RA,<br />
the efficacy of IL-23 and JAK inhibitors in axSpa, and<br />
the different targets in PsA treatment. Join us and get<br />
your cytokine signalling updates from <strong>EULAR</strong> 2023.<br />
Add the event to<br />
your calendar by<br />
registering here:<br />
bit.ly/<strong>CSF</strong><strong>Webinar</strong><br />
Register for FREE content at<br />
www.cytokinesignalling.com<br />
Follow us at:<br />
Cytokine Signalling Forum<br />
THIS WEBINAR IS INDEPENDENTLY PROVIDED<br />
BY THE CYTOKINE SIGNALLING FORUM AND<br />
SPONSORED BY<br />
DEVELOPED UNDER<br />
THE AUSPICES OF THE
Change language